🇺🇸 L-ascorbic acid in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 23

Most-reported reactions

1. Off Label Use — 4 reports (17.39%)
2. Drug Ineffective — 3 reports (13.04%)
3. Atrial Fibrillation — 2 reports (8.7%)
4. Dehydration — 2 reports (8.7%)
5. Drug Ineffective For Unapproved Indication — 2 reports (8.7%)
6. Dyspnoea — 2 reports (8.7%)
7. Interstitial Lung Disease — 2 reports (8.7%)
8. Joint Swelling — 2 reports (8.7%)
9. Pneumonia — 2 reports (8.7%)
10. Product Use In Unapproved Indication — 2 reports (8.7%)

Source database →

Frequently asked questions

Is L-ascorbic acid approved in United States?

L-ascorbic acid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for L-ascorbic acid in United States?

Virginia Commonwealth University is the originator. The local marketing authorisation holder may differ — check the official source linked above.